Compounds > risperidone
Page last updated: 2024-08-16

risperidone and tranylcypromine

risperidone has been researched along with tranylcypromine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Haura, G; Stoll, AL1
Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T1

Other Studies

4 other study(ies) available for risperidone and tranylcypromine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Tranylcypromine plus risperidone for treatment-refractory major depression.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:4

    Topics: Antipsychotic Agents; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Risperidone; Tranylcypromine

2000
Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models.
    Neuroscience letters, 2012, Oct-18, Volume: 528, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Brain; Clorgyline; Disease Models, Animal; Fluoxetine; Glutamic Acid; Male; Microdialysis; Monoamine Oxidase Inhibitors; Nitric Oxide; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Tranylcypromine

2012